Literature DB >> 20095558

Intermediacy of eudesmane cation during catalysis by aristolochene synthase.

Juan A Faraldos1, Benson Kariuki, Rudolf K Allemann.   

Abstract

Aristolochene synthase from Penicillium roqueforti (PR-AS) catalyzes the formation of the bicyclic sesquiterpene (+)-aristolochene (5) from farnesyl diphosphate (1, FDP) in two mechanistically distinct cyclization reactions. The first reaction transforms farnesyl diphosphate to the uncharged intermediate (S)-(-)-germacrene A (3) through a macrocyclization process that links C1 and C10 upon magnesium ion-assisted diphosphate ester activation. In the second reaction mediated by PR-AS, a protonation induced cyclization has been suggested to generate the highly reactive trans-fused eudesmane cation 4 as a consequence of the precise folding of the enzyme-bound germacrene A intermediate. This contribution describes the use of the transition state analogue inhibitor 4-aza-eudesm-11-ene to explore the intermediacy of cation 4 as an on-path intermediate in the biosynthesis of aristolochene. 4-Aza-eudesm-11-ene as the hydrochloride salt 6 was stereospecifically synthesized in seven steps and 37% overall yield starting from chiral enamine 9. The synthetic sequence featured a highly regio- and stereoselective deracemization reaction of 9 that gave rise to the corresponding Michael adduct in >95% diastereomeric excess as evidenced by optical rotation and NMR measurements. 6 acts as a potent competitive inhibitor of PR-AS (K(i) = 0.35 +/- 0.12 microM) independent of the presence of diphosphate (K(i) = 0.24 +/- 0.09 microM). The failure of exogenous PP(i) to enhance the binding affinity of 6 for PR-AS could be interpreted against an eudesmyl cation/diphosphate anion pair mechanism as the enzymatic strategy to stabilize the highly reactive eudesmane cation 4. In addition, these observations seem to rule out simple favorable electrostatic and/or hydrogen bonding interactions between the active site anchored diphosphate ion and the ammonium ion 6 as the binding mode. Ammonium ion 6 seems to act as a genuine mimic of eudesmane cation (4) that most likely binds the active site of PR-AS in a productive conformation resembling that adapted by 4 during the PR-AS-catalyzed synthesis of 5.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20095558     DOI: 10.1021/jo902397v

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  7 in total

Review 1.  Structural and Chemical Biology of Terpenoid Cyclases.

Authors:  David W Christianson
Journal:  Chem Rev       Date:  2017-08-25       Impact factor: 60.622

2.  Mechanistic insights from the binding of substrate and carbocation intermediate analogues to aristolochene synthase.

Authors:  Mengbin Chen; Naeemah Al-lami; Marine Janvier; Edward L D'Antonio; Juan A Faraldos; David E Cane; Rudolf K Allemann; David W Christianson
Journal:  Biochemistry       Date:  2013-08-01       Impact factor: 3.162

3.  Electrostatic effects on (di)terpene synthase product outcome.

Authors:  Ke Zhou; Reuben J Peters
Journal:  Chem Commun (Camb)       Date:  2011-02-08       Impact factor: 6.222

4.  Silent catalytic promiscuity in the high-fidelity terpene cyclase δ-cadinene synthase.

Authors:  Marianna Loizzi; David J Miller; Rudolf K Allemann
Journal:  Org Biomol Chem       Date:  2019-01-31       Impact factor: 3.876

5.  Sesquiterpene Synthase-Catalysed Formation of a New Medium-Sized Cyclic Terpenoid Ether from Farnesyl Diphosphate Analogues.

Authors:  Florence Huynh; Daniel J Grundy; Robert L Jenkins; David J Miller; Rudolf K Allemann
Journal:  Chembiochem       Date:  2018-07-16       Impact factor: 3.164

Review 6.  Germacrene A-A Central Intermediate in Sesquiterpene Biosynthesis.

Authors:  Houchao Xu; Jeroen S Dickschat
Journal:  Chemistry       Date:  2020-09-30       Impact factor: 5.236

7.  Comparative analysis and validation of the malachite green assay for the high throughput biochemical characterization of terpene synthases.

Authors:  Maria Vardakou; Melissa Salmon; Juan A Faraldos; Paul E O'Maille
Journal:  MethodsX       Date:  2014-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.